Related Experiment Video
Updated: Aug 12, 2026

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples
Published on: April 21, 2014
[Genetic heterogeneity of hypertrophic cardiomyopathy in Japanese]
1Department of Cardiovascular Medicine, Hokkaido University School of Medicine, Sapporo, Japan.
Insights
Genetic analysis of Japanese hypertrophic cardiomyopathy (HCM) revealed limited missense mutations in the beta-myosin heavy chain (beta-MHC) gene. These findings suggest different genetic causes for HCM in Japanese versus Caucasian populations.
Area of Science:
- Cardiovascular Genetics
- Molecular Cardiology
- Human Genetics
Background:
- Familial hypertrophic cardiomyopathy (FHCM) is often linked to beta-myosin heavy chain (beta-MHC) gene mutations in Caucasian populations.
- Previous studies suggest a distinct genetic linkage for Japanese FHCM, associated with DNA marker PALB on chromosome 18q.
Purpose of the Study:
- To investigate the etiological significance of beta-myosin heavy chain (beta-MHC) gene mutations in Japanese hypertrophic cardiomyopathy (HCM) patients.
- To identify sequence variations in exons 3-25 of the beta-MHC gene in Japanese FHCM kindreds and sporadic patients.
Main Methods:
- Polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) was employed to analyze beta-MHC gene sequences.
- Linkage analysis was performed using DNA markers F13B (chromosome 1q) and D11S916 (chromosome 11p-q).
Main Results:
- Only one missense mutation (codon 741) was identified in a single Japanese FHCM kindred.
- Two synonymous mutations were found in another kindred, with one also present in a sporadic patient.
- Statistically negative linkage was observed with markers F13B and D11S916, suggesting they are not primary causes in these families.
Conclusions:
- The beta-myosin heavy chain (beta-MHC) gene mutations are less prevalent in Japanese HCM patients compared to Caucasians.
- Multiple causative genes likely contribute to HCM in the Japanese population.
- The primary genetic determinants of HCM in Japanese individuals appear to differ from those in Caucasian populations.
Abstract:
Familial hypertrophic cardiomyopathy (FHCM) is thought to be caused by missense mutations in cardiac beta-myosin heavy chain (beta-MHC) gene in 30-40% of affected Caucasian individuals. On the other hand, it has been reported that Japanese FHCM is closely linked to DNA marker PALB on chromosome 18q by linkage analysis. Therefore, in order to elucidate the etiological significance of missense mutations in beta-MHC gene in Japanese HCM patients, we have investigated the sequence variation in exon 3 to 25 of beta-MHC gene from 16 multiplex FHCM kindreds and 28 sporadic patients by polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP) method. In this study we demonstrated one missense mutation (codon741: GlyGGG-->ArgAGG) in only one kindred among 16 multiplex Japanese kindreds with FHCM. Two synonymous mutations (codon715: TryTAC-->TryTAT, codon 989: IleATT-->IleATC) are demonstrated in another kindred. The same mutation in codon 989 is also detected in one sporadic patient. Furthermore, we performed linkage study with two DNA markers (F13B on chromosome 1q, D11S916: AMF185yal on chromosome 11p-q) which are recently reported to be linked with FHCM. Three and four families showed statistically negative linkage with F13B and D11S916 (AMF185yal), respectively. These results suggest that several responsible genes for HCM may exist in Japanese and principal responsible gene for Japanese HCM is different from it for Caucasian HCM.
Related Concept Videos
Specialized Characteristics of Cardiac Muscles
Cardiac muscle cells are smaller than skeletal muscles, averaging 10–20 mm in diameter and 50–100 mm in length. However, they have large energy demands for continuous contraction and relaxation. This energy is almost exclusively derived from aerobic metabolism of energy reserves in...
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy

